Business Wire

New Data from PROMISES Study Shows PREVENA™ Incision Management System Significantly Reduces Major Complications and Readmissions Compared to Standard of Care

ST. PAUL, Minn.--(BUSINESS WIRE)--3M today announced new data demonstrating the PREVENA™ Incision Management System significantly mitigated 90-day surgical site complications (SSCs) and readmission ...
Business Wire

PREVENA™ Therapy Becomes the First and Only Negative Pressure Medical Device FDA-Indicated to Aid in the Reduction of Superficial Surgical Site Infections (SSIs) in Patients ...

SAN ANTONIO--(BUSINESS WIRE)--KCI, an Acelity Company, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company’s De Novo request for the PREVENA™ Incision Management ...